Article

Rite Aid Expands Naloxone Dispensing Program in 6 Additional States

Rite Aid has announced that naloxone is now available at more than 630 pharmacies in Georgia, Louisiana, Tennessee, Utah, Virginia and West Virginia without a prescription.

PRESS RELEASE

Camp Hill, Pa. (Feb. 15, 2017) - Rite Aid announced today that naloxone, a medication that can be used to reverse the effects of an opioid overdose, is now available at more than 630 pharmacies in Georgia, Louisiana, Tennessee, Utah, Virginia and West Virginia without a prescription, subject to state regulations. Previously, naloxone, which can be administered by injection or nasal spray, was only available with a physician's prescription.

"As the epidemic continues to grow, as evidenced in the Centers for Disease Control and Prevention recent statistic, 91 people die every day from an opioid overdose in the United States," said Jocelyn Konrad, Rite Aid executive vice president of pharmacy. "With the ability to dispense naloxone without a prescription in more than 20 states, Rite Aid is not only showing its commitment to increasing customer access to this potentially lifesaving medication, but we are also raising awareness and helping fight drug abuse in the communities we serve."

Naloxone is also available for purchase without patient specific prescriptions at Rite Aid pharmacies in 17 additional states including: Alabama, California, Colorado, Connecticut, Idaho, Indiana, Kentucky, Massachusetts, Maryland, North Carolina, New Hampshire, New York, Ohio, Oregon, Pennsylvania, Rhode Island and Vermont.

To date, Rite Aid has trained more than 10,000 pharmacists on naloxone dispensing. Rite Aid is also working to expand its naloxone dispensing program in other states served by the Company where naloxone is currently only available with a prescription.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Image credit: Sebastian Kaulitzki | stock.adobe.com
Health and nutrition: the role of glp-1 in diabetes management with apple and syringe - Image credit: Thanayut | stock.adobe.com
Image credit: K KStock | stock.adobe.com
Image credit: komokvm | stock.adobe.com
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Vaccine vials used for Respiratory Syncytial Virus (RSV) with a syringe - Image credit:  Peter Hansen | stock.adobe.com